Now showing items 1-10 of 25
Clinical and color Doppler ultrasound evaluation of polyacrylamide injection in HIV patients with severe facial lipoatrophy secondary to antiretroviral therapy
(Blackwell Publishing Ltd, 2017)
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background/Purpose: Facial lipoatrophy in HIV patients, secondary to antiretroviral therapy (ART) with thymidine analogs, has been related to important ...
Facial Lipoatrophy: Appearances Are Not Deceiving
(ELSEVIER SCIENCE INC, 2009)
Lipodystrophy syndrome (LS) has been reported as visible markers that cat? identify HIV status. Changes in body shape are detrimental in terms of psychological welfare and may affect well-being and increase the stigma ...
Impacto de la auto - percepción de imagen corporal en sujetos con VIH y lipoatrofia facial.
(Universidad del RosarioEspecialización en Medicina Estética y laserFacultad de Medicina, 2012)
Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models
(BioMed Central, 2018)
Abstract Background Body composition alterations, or lipodystrophy, can lead to serious health problems in people living with HIV/AIDS (PLWHA). The objectives of this study ...
Avaliação do uso do ácido poli-l-láctico no tratamento da lipoatrofia facial associada à terapia antirretroviral em pacientes soropositivos para o vírus da imunodeficiência humana
(Universidade Federal de São Paulo (UNIFESP), 2009-06-24)
Background: Lipodystrophy was first described in 1998, after the beginning of HAART era, in context of improvement of morbidity and mortality of HIV patients. Changes in physical aspects interfere with social relationships, ...
Subcutaneous lipoatrophy and skin depigmentation secondary to TMJ intra-articular corticosteroid injection
Chronic orofacial pain is a complex multidimensional experience that produces disability and impairment of normal mandibular function. Overall estimations of chronic orofacial pain prevalence are 7 to 11% of the general ...
Treatment of HIV-associated facial lipoatrophy: impact on infection progression assessed by viral load and CD4 count
(Sociedade Brasileira de Dermatologia, 2013-08-01)
BACKGROUND:HIV/AIDS-Associated Lipodystrophy Syndrome includes changes in body fat distribution, with or without metabolic changes. The loss of fat from the face, called facial lipoatrophy, is one of the most stigmatizing ...